Theravance Biopharma, Inc. · NASDAQ:TBPH

Newtyn Management, LLC's stake in Theravance Biopharma, Inc. fell to 6.70% (Schedule 13G/A)

Event Jun 30, 2026 · Filed Aug 14, 2026

Newtyn Management, LLC's stake in Theravance Biopharma, Inc. fell to 6.70%, 3,434,191 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G/A).

Stake
6.70%
Shares
3,434,191
Intent
Passive
What changed
Fell below 5%
Filed together
2 holders

The filing in full

HolderStakeShares
Newtyn Management, LLC6.70%3,434,191
Newtyn TE Partners, LP4.30%2,212,712

Source

View original at SEC

Related